Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
NEUE 
NeueHealth Inc (NEUE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/03/2025: NEUE (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $7
1 Year Target Price $7
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -80.99% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 60.94M USD | Price to earnings Ratio - | 1Y Target Price 7 |
Price to earnings Ratio - | 1Y Target Price 7 | ||
Volume (30-day avg) 2 | Beta 0.6 | 52 Weeks Range 3.79 - 7.66 | Updated Date 10/14/2025 |
52 Weeks Range 3.79 - 7.66 | Updated Date 10/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -17.65 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.2% | Operating Margin (TTM) 6.82% |
Management Effectiveness
Return on Assets (TTM) -1.96% | Return on Equity (TTM) -183.26% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1049226692 | Price to Sales(TTM) 0.07 |
Enterprise Value 1049226692 | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 1.18 | Enterprise Value to EBITDA -0.73 | Shares Outstanding 9024240 | Shares Floating 3978287 |
Shares Outstanding 9024240 | Shares Floating 3978287 | ||
Percent Insiders 9.45 | Percent Institutions 58.37 |
Upturn AI SWOT
NeueHealth Inc
Company Overview
History and Background
NeueHealth Inc. was founded in 2015 as Bright Health Group. It focused on integrating care delivery with health insurance plans, primarily through its NeueCare provider network. In 2024 the company rebranded as NeueHealth Inc., refocusing on care delivery and value-based care enablement. Bright Health Group filed for bankruptcy in 2023.
Core Business Areas
- NeueCare: The core business focuses on integrated care delivery. It offers primary and specialty care services through owned and affiliated clinics, aiming to improve patient outcomes and lower costs through value-based care models.
- Care Enablement: Offers technology and services to help other providers adopt value-based care models. This includes data analytics, population health management tools, and risk-bearing capabilities.
Leadership and Structure
Mike Mikan is the CEO. The organizational structure is centered around the NeueCare and Care Enablement business segments, with functional departments supporting these operations.
Top Products and Market Share
Key Offerings
- Primary Care Services: NeueCare provides comprehensive primary care services, including preventive care, chronic disease management, and acute care. Market share data specific to NeueCare is unavailable as it operates within a fragmented market. Competitors include Oak Street Health (OAK), One Medical (AMZN), and traditional physician groups.
- Value-Based Care Enablement Platform: The platform provides data analytics and technology to enable providers to manage populations and participate in value-based care arrangements. No specific market share is available. Competitors include Evolent Health (EVH), and other population health management technology vendors.
Market Dynamics
Industry Overview
The healthcare industry is undergoing a shift towards value-based care, driven by rising costs and a focus on improving patient outcomes. This involves moving away from fee-for-service models to payment structures that reward quality and efficiency.
Positioning
NeueHealth Inc. positions itself as a leader in integrated care delivery and value-based care enablement, aiming to bridge the gap between payers and providers. Its competitive advantage lies in its integrated NeueCare network and technology platform.
Total Addressable Market (TAM)
The TAM for value-based care is estimated to be in the hundreds of billions of dollars annually. NeueHealth Inc. is positioned to capture a portion of this market by enabling providers to participate in value-based arrangements and delivering integrated care.
Upturn SWOT Analysis
Strengths
- Integrated NeueCare network
- Value-based care expertise
- Care Enablement Platform
- Experienced leadership team
Weaknesses
- High debt levels following Bright Health bankruptcy.
- Limited operating history as a standalone entity.
- Execution risk in scaling NeueCare and Care Enablement.
- Reliance on key partnerships.
Opportunities
- Growth in value-based care adoption
- Expansion of NeueCare network
- Increased demand for care enablement solutions
- Strategic partnerships with payers and providers
Threats
- Regulatory changes in healthcare
- Increased competition in value-based care
- Economic downturn impacting healthcare spending
- Provider network disruption
Competitors and Market Share
Key Competitors
- OAK
- AMZN
- EVH
Competitive Landscape
NeueHealth Inc. faces competition from established players in value-based care and healthcare technology. Its success depends on differentiating its integrated care model and care enablement platform.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is not representative of the company's current trajectory due to the bankruptcy of Bright Health Group and subsequent restructuring.
Future Projections: Future growth projections depend on successful execution of the NeueCare and Care Enablement strategies. Analyst estimates vary widely.
Recent Initiatives: The rebranding to NeueHealth Inc. and refocus on value-based care are the primary recent initiatives.
Summary
NeueHealth Inc. is in a transitional phase following the bankruptcy of Bright Health Group and the strategic refocus on value-based care delivery. Its success hinges on effectively scaling its NeueCare network and care enablement platform. The company faces execution risks and competition in a rapidly evolving healthcare landscape. Financial stability and successful strategic partnerships will be key to its future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company press releases
- SEC filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NeueHealth Inc
Exchange NYSE | Headquaters Doral, FL, United States | ||
IPO Launch date 2021-06-24 | Vice Chairman, CEO & President Mr. George Lawrence Mikan III | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 986 | Website https://www.neuehealth.com |
Full time employees 986 | Website https://www.neuehealth.com | ||
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates in two segments, NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health and Premier Medical Associates brand names. This segment also offers integrated system care solutions, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.